Related Experiment Videos
Risks versus benefits of testosterone therapy in elderly men
1Division of Endocrinology and Metabolism, Johns Hopkins University, Baltimore, Maryland 21287, USA.
Drugs & Aging
|September 24, 1999
Summary
Testosterone replacement therapy may benefit elderly men with hypogonadism, improving muscle strength and bone density. Careful monitoring is essential to manage potential risks like polycythemia.
Area of Science:
- Gerontology
- Endocrinology
- Men's Health
Background:
- 'Andropause' and age-related testosterone decline are increasingly recognized.
- Symptoms of hypogonadism in elderly men are often nonspecific, leading to debate on androgen replacement.
- Testosterone levels naturally decrease with age due to central and peripheral factors, affecting circadian rhythm and SHBG levels.
Purpose of the Study:
- To review the benefits and risks of androgen replacement therapy in hypogonadal elderly men.
- To address controversies regarding testosterone level cutoffs and measurement methods (free vs. total).
- To provide recommendations for initiating and monitoring testosterone therapy.
Main Methods:
- Literature review of studies on testosterone replacement in elderly men.
- Analysis of age-related changes in testosterone production and regulation.
- Evaluation of evidence for testosterone's effects on various physiological systems.
Main Results:
- Testosterone replacement improves muscle strength, bone mineral density, and the hematopoietic system.
- Conflicting data exists regarding effects on cognition and lipoprotein profiles.
- Potential adverse effects include polycythemia and sleep apnea, particularly concerning for men with cardiac issues.
Conclusions:
- Elderly men with hypogonadism symptoms and total testosterone <300 ng/dl may benefit from testosterone replacement.
- Prostate cancer is a contraindication for androgen therapy.
- Regular patient follow-up is crucial to prevent and manage therapy-related complications.